BackPear Therapeutics Overview

Pear Therapeutics Current Assets

Track Pear Therapeutics's current assets ($73M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$72.96M
60.61% YoYΔ $-112.28M vs prior year quarter

Peer trimmed avg / median

Loading

Pear Therapeutics Current Assets History

Loading

Pear Therapeutics vs. peers: Current Assets Comparison

Loading

Pear Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pear Therapeutics (PEAR) FAQ

As of the most recent data (December 2022), PEAR shows a current assets of $73M. That compares with $190M in the prior-year period — down 60.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PEAR's current assets is now $73M (was $190M) — a 60.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pear Therapeutics is outperforming or lagging.

Tracking PEAR's current assets over time shows whether Pear Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $73M That compares with $190M in the prior-year period — down 60.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Pear Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $73M) with ownership activity and broader fundamentals.